by Truveta staff | Jan 23, 2024 | Research
Overall, the rate of hospitalizations associated with respiratory viruses continues to increase (92.8% increase from November 2023 to the end of December 2023). The largest increases in hospitalizations over the past month were associated with influenza (251.7%...
by Truveta staff | Dec 15, 2023 | Research
As 2023 draws to a close and we reflect on a busy and exciting year for Truveta, something that stands out is the breadth and depth of research Truveta Research has been able to produce using Truveta Data and Truveta Studio. From studying new Alzheimer’s disease...
by Truveta staff | Sep 28, 2023 | Technology
It’s only September, but COVID-19 and respiratory syncytial virus (RSV) cases are already rising. The latest Truveta Research monitoring report shows that for people over 65, COVID continues to be the most prevalent respiratory virus associated with hospitalizations....
by Truveta staff | Aug 22, 2023 | Data
RSV season, which typically starts in fall and peaks in winter, could look very different this year. With newly approved vaccines for older adults and pregnant women and an immunization for infants poised to roll out, public health experts are optimistic about...
by Truveta Research | Jan 13, 2023 | Research, Research Insights
Intended for a scientific audience, Truveta Research Technical Reports are a new way of looking at the timely, representative, and de-identified data in Truveta Studio. The Truveta Research blog will surface insights shown in these Technical Reports for a broader...
